Question 1

What is the catalog number for C10orf67 CRISPR Knock Out 293T Cell Line (Human)?

Accepted Answer

The catalog number for C10orf67 CRISPR Knock Out 293T Cell Line (Human) is 13659141.

Question 2

What sizes are available for C10orf67 CRISPR Knock Out 293T Cell Line (Human)?

Accepted Answer

C10orf67 CRISPR Knock Out 293T Cell Line (Human) is available in the following size(s): 1x 10^6 Cells / 1.0 mL.

Question 3

Is C10orf67 CRISPR Knock Out 293T Cell Line (Human) in stock?

Accepted Answer

C10orf67 CRISPR Knock Out 293T Cell Line (Human) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

Question 5

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 6

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

C10orf67 CRISPR Knock Out 293T Cell Line (Human)

Product Specifications

Gene Name

Gene Aliases

Accession Number

Reactivity

Shipping Conditions

Storage Conditions

Frequently Asked Questions

Explore Other Products

Human Herpes Virus 8 (HHV8) (LN53), Biotin conjugate, 0.1mg/mL

C-Myc Oncoprotein (MYC2895R), 0.2mg/mL

S100A4 / Metastasin / Calvasculin (Marker of Tumor Metastasis) (rS100A4/1481), CF640R conjugate, 0.1mg/mL

Anti-LIM and SH3 domain protein 1 LASP1 Antibody Picoband®, PE Conjugate

HLA-DRB (LN-3 + HLA-DRB/1067), CF740 conjugate, 0.1mg/mL

Anti-RANK/TNFRSF11A Antibody Picoband® (Dylight488 Conjugate)